Correlation Between Exagen and OncoCyte Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Exagen and OncoCyte Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exagen and OncoCyte Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exagen Inc and OncoCyte Corp, you can compare the effects of market volatilities on Exagen and OncoCyte Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exagen with a short position of OncoCyte Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exagen and OncoCyte Corp.

Diversification Opportunities for Exagen and OncoCyte Corp

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Exagen and OncoCyte is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Exagen Inc and OncoCyte Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoCyte Corp and Exagen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exagen Inc are associated (or correlated) with OncoCyte Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoCyte Corp has no effect on the direction of Exagen i.e., Exagen and OncoCyte Corp go up and down completely randomly.

Pair Corralation between Exagen and OncoCyte Corp

Considering the 90-day investment horizon Exagen Inc is expected to generate 1.68 times more return on investment than OncoCyte Corp. However, Exagen is 1.68 times more volatile than OncoCyte Corp. It trades about 0.11 of its potential returns per unit of risk. OncoCyte Corp is currently generating about -0.1 per unit of risk. If you would invest  290.00  in Exagen Inc on August 31, 2024 and sell it today you would earn a total of  94.00  from holding Exagen Inc or generate 32.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Exagen Inc  vs.  OncoCyte Corp

 Performance 
       Timeline  
Exagen Inc 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.
OncoCyte Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OncoCyte Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Exagen and OncoCyte Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Exagen and OncoCyte Corp

The main advantage of trading using opposite Exagen and OncoCyte Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exagen position performs unexpectedly, OncoCyte Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoCyte Corp will offset losses from the drop in OncoCyte Corp's long position.
The idea behind Exagen Inc and OncoCyte Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing